OBJECTIVE: Tetrahydrobiopterin (BH(4)) deficiency is a cause of dystonia at birth. We hypothesized that BH(4) is a developmental factor determining vulnerability of the immature fetal brain to hypoxic-ischemic injury and subsequent motor deficits in newborns. METHODS: Pregnant rabbits were subjected to 40-minute uterine ischemia, and fetal brains were investigated for global and focal changes in BH(4). Newborn kits were assessed by neurobehavioral tests following vehicle and sepiapterin (BH(4) analog) treatment of dams. RESULTS: Naive fetal brains at 70% gestation (E22) were severely deficient for BH(4) compared with maternal and other fetal tissues. BH(4) concentration rapidly increased normally in the perinatal period, with the highest concentrations found in the thalamus compared with basal ganglia, frontal, occipital, hippocampus, and parietal cortex. Global sustained 40-minute hypoxia-ischemia depleted BH(4) in E22 thalamus and to a lesser extent in basal ganglia, but not in the frontal, occipital, and parietal regions. Maternal supplementation prior to hypoxia-ischemia with sepiapterin increased BH(4) in all brain regions and especially in the thalamus, but did not increase the intermediary metabolite, 7,8-BH(2). Sepiapterin treatment also reduced incidence of severe motor deficits and perinatal death following E22 hypoxia-ischemia. INTERPRETATION: We conclude that early developmental BH(4) deficiency plays a critical role in hypoxic-ischemic brain injury. Increasing brain BH(4) via maternal supplementation may be an effective strategy in preventing motor deficits from antenatal hypoxia-ischemia.
OBJECTIVE:Tetrahydrobiopterin (BH(4)) deficiency is a cause of dystonia at birth. We hypothesized that BH(4) is a developmental factor determining vulnerability of the immature fetal brain to hypoxic-ischemic injury and subsequent motor deficits in newborns. METHODS: Pregnant rabbits were subjected to 40-minute uterine ischemia, and fetal brains were investigated for global and focal changes in BH(4). Newborn kits were assessed by neurobehavioral tests following vehicle and sepiapterin (BH(4) analog) treatment of dams. RESULTS: Naive fetal brains at 70% gestation (E22) were severely deficient for BH(4) compared with maternal and other fetal tissues. BH(4) concentration rapidly increased normally in the perinatal period, with the highest concentrations found in the thalamus compared with basal ganglia, frontal, occipital, hippocampus, and parietal cortex. Global sustained 40-minute hypoxia-ischemia depleted BH(4) in E22 thalamus and to a lesser extent in basal ganglia, but not in the frontal, occipital, and parietal regions. Maternal supplementation prior to hypoxia-ischemia withsepiapterin increased BH(4) in all brain regions and especially in the thalamus, but did not increase the intermediary metabolite, 7,8-BH(2). Sepiapterin treatment also reduced incidence of severe motor deficits and perinatal death following E22 hypoxia-ischemia. INTERPRETATION: We conclude that early developmental BH(4) deficiency plays a critical role in hypoxic-ischemic brain injury. Increasing brain BH(4) via maternal supplementation may be an effective strategy in preventing motor deficits from antenatal hypoxia-ischemia.
Authors: Robert D Barrett; Laura Bennet; Joanne Davidson; Justin M Dean; Sherly George; Bright S Emerald; Alistair Jan Gunn Journal: Birth Defects Res C Embryo Today Date: 2007-09
Authors: Diane L Damiano; Jeffrey M Quinlivan; Bryan F Owen; Patricia Payne; Karen C Nelson; Mark F Abel Journal: Dev Med Child Neurol Date: 2002-02 Impact factor: 5.449
Authors: Matthew Derrick; Ning Ling Luo; Joanne C Bregman; Tamas Jilling; Xinhai Ji; Kara Fisher; Candece L Gladson; Douglas J Beardsley; Geoffrey Murdoch; Stephen A Back; Sidhartha Tan Journal: J Neurosci Date: 2004-01-07 Impact factor: 6.167
Authors: Marcel M Verbeek; Gerry C H Steenbergen-Spanjers; Michèl A A P Willemsen; Frans A Hol; Jan Smeitink; Jürgen Seeger; Padraic Grattan-Smith; Monique M Ryan; Georg F Hoffmann; Maria A Donati; Nenad Blau; Ronald A Wevers Journal: Ann Neurol Date: 2007-10 Impact factor: 10.422
Authors: Monica Williams; Zhi Zhang; Elizabeth Nance; Julia L Drewes; Wojciech G Lesniak; Sarabdeep Singh; Diane C Chugani; Kannan Rangaramanujam; David R Graham; Sujatha Kannan Journal: Dev Neurosci Date: 2017-05-11 Impact factor: 2.984
Authors: Lei Yu; Matthew Derrick; Haitao Ji; Richard B Silverman; Jennifer Whitsett; Jeannette Vásquez-Vivar; Sidhartha Tan Journal: Dev Neurosci Date: 2011-06-10 Impact factor: 2.984
Authors: Alexander Drobyshevsky; Silvia Honda Takada; Kehuan Luo; Matthew Derrick; Lei Yu; Katharina A Quinlan; Jeannette Vasquez-Vivar; Maria Inês Nogueira; Sidhartha Tan Journal: J Neurochem Date: 2015-01-23 Impact factor: 5.372
Authors: Nicola J Robertson; Sidhartha Tan; Floris Groenendaal; Frank van Bel; Sandra E Juul; Laura Bennet; Matthew Derrick; Stephen A Back; Raul Chavez Valdez; Frances Northington; Alistair Jan Gunn; Carina Mallard Journal: J Pediatr Date: 2012-02-09 Impact factor: 4.406
Authors: Savitha Sethumadhavan; Jennifer Whitsett; Brian Bennett; Irina A Ionova; Galen M Pieper; Jeannette Vasquez-Vivar Journal: Free Radic Biol Med Date: 2016-01-27 Impact factor: 7.376
Authors: Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree Journal: Antioxid Redox Signal Date: 2014-03-14 Impact factor: 8.401